Epstein Files Full PDF

CLICK HERE
Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

  • Registerasi
  • Brosur UTI
  • Kip Scholarship Information
  • Performance
Flag Counter
  1. World Encyclopedia
  2. RIP kinase - Wikipedia
RIP kinase - Wikipedia
From Wikipedia, the free encyclopedia

RIP kinases (receptor-interacting protein kinases) are a class of serine/threonine protein kinases. In humans, five different RIP kinases are known:

  • RIPK1
  • RIPK2
  • RIPK3
  • RIPK4
  • RIPK5

Further reading

[edit]
  • Zhang, Duanwu; Lin, Juan; Han, Jiahuai (July 2010). "Receptor-interacting protein (RIP) kinase family". Cellular & Molecular Immunology. 7 (4): 243–249. doi:10.1038/cmi.2010.10. PMC 4003224. PMID 20383176.
  • v
  • t
  • e
Kinases: Serine/threonine-specific protein kinases (EC 2.7.11-12)
Serine/threonine-specific protein kinases (EC 2.7.11.1-EC 2.7.11.20)
Non-specific serine/threonine protein kinases (EC 2.7.11.1)
  • LATS1
  • LATS2
  • MAST1
  • MAST2
  • STK38
  • STK38L
  • CIT
  • ROCK1
  • SGK
  • SGK2
  • SGK3
  • Protein kinase B
    • AKT1
    • AKT2
    • AKT3
  • Ataxia telangiectasia mutated
  • mTOR
  • EIF-2 kinases
    • PKR
    • HRI
    • EIF2AK3
    • EIF2AK4
  • Wee1
    • WEE1
Pyruvate dehydrogenase kinase (EC 2.7.11.2)
  • PDK1
  • PDK2
  • PDK3
  • PDK4
Dephospho-(reductase kinase) kinase (EC 2.7.11.3)
  • AMP-activated protein kinase α
    • PRKAA1
    • PRKAA2
  • β
    • PRKAB1
    • PRKAB2
  • γ
    • PRKAG1
    • PRKAG2
    • PRKAG3
3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring) kinase (EC 2.7.11.4)
  • BCKDK
  • BCKDHA
  • BCKDHB
(isocitrate dehydrogenase (NADP+)) kinase (EC 2.7.11.5)
  • IDH2
  • IDH3A
  • IDH3B
  • IDH3G
(tyrosine 3-monooxygenase) kinase (EC 2.7.11.6)
  • STK4
Myosin-heavy-chain kinase (EC 2.7.11.7)
  • Aurora kinase
    • Aurora A kinase
    • Aurora B kinase
    • Aurora C kinase
Fas-activated serine/threonine kinase (EC 2.7.11.8)
  • FASTK
  • STK10
Goodpasture-antigen-binding protein kinase (EC 2.7.11.9)
  • -
IκB kinase (EC 2.7.11.10)
  • CHUK
  • IKK2
  • TBK1
  • IKBKE
  • IKBKG
  • IKBKAP
cAMP-dependent protein kinase (EC 2.7.11.11)
  • Protein kinase A
  • PRKACG
  • PRKACB
  • PRKACA
  • PRKY
cGMP-dependent protein kinase (EC 2.7.11.12)
  • Protein kinase G
  • PRKG1
Protein kinase C (EC 2.7.11.13)
  • Protein kinase C
  • Protein kinase Cζ
  • PKC alpha
  • PRKCB1
  • PRKCD
  • PRKCE
  • PRKCH
  • PRKCG
  • PRKCI
  • PRKCQ
  • Protein kinase N1
  • PKN2
  • PKN3
Rhodopsin kinase (EC 2.7.11.14)
  • Rhodopsin kinase
Beta adrenergic receptor kinase (EC 2.7.11.15)
  • Beta adrenergic receptor kinase
  • Beta adrenergic receptor kinase-2
G-protein coupled receptor kinases (EC 2.7.11.16)
  • GRK4
  • GRK5
  • GRK6
Ca2+/calmodulin-dependent (EC 2.7.11.17)
  • BRSK2
  • CAMK1
  • CAMK1A
  • CAMK1B
  • CAMK1D
  • CAMK1G
  • CAMK2
  • CAMK2A
  • CAMK2B
  • CAMK2D
  • CAMK2G
  • CAMK4
  • MLCK
  • CASK
  • CHEK1
  • CHEK2
  • DAPK1
  • DAPK2
  • DAPK3
  • STK11
  • MAPKAPK2
  • MAPKAPK3
  • MAPKAPK5
  • MARK1
  • MARK2
  • MARK3
  • MARK4
  • MELK
  • MKNK1
  • MKNK2
  • NUAK1
  • NUAK2
  • OBSCN
  • PASK
  • PHKG1
  • PHKG2
  • PIM1
  • PIM2
  • PKD1
  • PRKD2
  • PRKD3
  • PSKH1
  • SNF1LK2
  • KIAA0999
  • STK40
  • SNF1LK
  • SNRK
  • SPEG
  • TSSK2
  • Kalirin
  • TRIB1
  • TRIB2
  • TRIB3
  • TRIO
  • Titin
  • DCLK1
Myosin light-chain kinase (EC 2.7.11.18)
  • MYLK
  • MYLK2
  • MYLK3
  • MYLK4
Phosphorylase kinase (EC 2.7.11.19)
  • PHKA1
  • PHKA2
  • PHKB
  • PHKG1
  • PHKG2
Elongation factor 2 kinase (EC 2.7.11.20)
  • EEF2K
  • STK19
Polo kinase (EC 2.7.11.21)
  • PLK1
  • PLK2
  • PLK3
  • PLK4
Serine/threonine-specific protein kinases (EC 2.7.11.21-EC 2.7.11.30)
Polo kinase (EC 2.7.11.21)
  • PLK1
  • PLK2
  • PLK3
  • PLK4
Cyclin-dependent kinase (EC 2.7.11.22)
  • CDK1
  • CDK2
  • CDKL2
  • CDK3
  • CDK4
  • CDK5
  • CDKL5
  • CDK6
  • CDK7
  • CDK8
  • CDK9
  • CDK10
  • CDK12
  • CDC2L5
  • PCTK1
  • PCTK2
  • PCTK3
  • PFTK1
  • CDC2L1
(RNA-polymerase)-subunit kinase (EC 2.7.11.23)
  • RPS6KA5
  • RPS6KA4
  • P70S6 kinase
  • P70-S6 Kinase 1
  • RPS6KB2
  • RPS6KA2
  • RPS6KA3
  • RPS6KA1
  • RPS6KC1
Mitogen-activated protein kinase (EC 2.7.11.24)
  • Extracellular signal-regulated
    • MAPK1
    • MAPK3
    • MAPK4
    • MAPK6
    • MAPK7
    • MAPK12
    • MAPK15
  • C-Jun N-terminal
    • MAPK8
    • MAPK9
    • MAPK10
  • P38 mitogen-activated protein
    • MAPK11
    • MAPK13
    • MAPK14
MAP3K (EC 2.7.11.25)
  • MAP kinase kinase kinases
    • MAP3K1
    • MAP3K2
    • MAP3K3
    • MAP3K4
    • MAP3K5
    • MAP3K6
    • MAP3K7
    • MAP3K8
  • RAFs
    • ARAF
    • BRAF
    • KSR1
    • KSR2
  • MLKs
    • MAP3K12
    • MAP3K13
    • MAP3K9
    • MAP3K10
    • MAP3K11
    • MAP3K7
    • ZAK
  • CDC7
  • MAP3K14
Tau-protein kinase (EC 2.7.11.26)
  • TPK1
  • TTK
  • GSK-3
(acetyl-CoA carboxylase) kinase (EC 2.7.11.27)
  • -
Tropomyosin kinase (EC 2.7.11.28)
  • -
Low-density-lipoprotein receptor kinase (EC 2.7.11.29)
  • -
Receptor protein serine/threonine kinase (EC 2.7.11.30)
  • Bone morphogenetic protein receptors
    • BMPR1
    • BMPR1A
    • BMPR1B
    • BMPR2
  • ACVR1
  • ACVR1B
  • ACVR1C
  • ACVR2A
  • ACVR2B
  • ACVRL1
  • Anti-Müllerian hormone receptor
Dual-specificity kinases (EC 2.7.12)
MAP2K
  • MAP2K1
  • MAP2K2
  • MAP2K3
  • MAP2K4
  • MAP2K5
  • MAP2K6
  • MAP2K7
  • v
  • t
  • e
Enzymes
Activity
  • Active site
  • Binding site
  • Catalytic triad
  • Oxyanion hole
  • Enzyme promiscuity
  • Diffusion-limited enzyme
  • Cofactor
  • Enzyme catalysis
Regulation
  • Allosteric regulation
  • Cooperativity
  • Enzyme inhibitor
  • Enzyme activator
Classification
  • EC number
  • Enzyme superfamily
  • Enzyme family
  • List of enzymes
Kinetics
  • Enzyme kinetics
  • Eadie–Hofstee diagram
  • Hanes–Woolf plot
  • Lineweaver–Burk plot
  • Michaelis–Menten kinetics
Types
  • EC1 Oxidoreductases (list)
  • EC2 Transferases (list)
  • EC3 Hydrolases (list)
  • EC4 Lyases (list)
  • EC5 Isomerases (list)
  • EC6 Ligases (list)
  • EC7 Translocases (list)
Portal:
  • icon Biology

\


Stub icon

This EC 2.7 enzyme-related article is a stub. You can help Wikipedia by adding missing information.

  • v
  • t
  • e
Retrieved from "https://teknopedia.ac.id/w/index.php?title=RIP_kinase&oldid=995918374"
Categories:
  • EC 2.7.11
  • Human proteins
  • Protein kinases
  • EC 2.7 stubs
Hidden category:
  • All stub articles

  • indonesia
  • Polski
  • العربية
  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • مصرى
  • Nederlands
  • 日本語
  • Português
  • Sinugboanong Binisaya
  • Svenska
  • Українська
  • Tiếng Việt
  • Winaray
  • 中文
  • Русский
Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id